<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37304792</PMID><DateRevised><Year>2024</Year><Month>07</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2632-1297</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>3</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Brain communications</Title><ISOAbbreviation>Brain Commun</ISOAbbreviation></Journal><ArticleTitle>Neural dysregulation in post-COVID fatigue.</ArticleTitle><Pagination><StartPage>fcad122</StartPage><MedlinePgn>fcad122</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">fcad122</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/braincomms/fcad122</ELocationID><Abstract><AbstractText>Following infection with SARS-CoV-2, a substantial minority of people develop lingering after-effects known as 'long COVID'. Fatigue is a common complaint with a substantial impact on daily life, but the neural mechanisms behind post-COVID fatigue remain unclear. We recruited 37 volunteers with self-reported fatigue after a mild COVID infection and carried out a battery of behavioural and neurophysiological tests assessing the central, peripheral and autonomic nervous systems. In comparison with age- and sex-matched volunteers without fatigue (<i>n</i> = 52), we show underactivity in specific cortical circuits, dysregulation of autonomic function and myopathic change in skeletal muscle. Cluster analysis revealed no subgroupings, suggesting post-COVID fatigue is a single entity with individual variation, rather than a small number of distinct syndromes. Based on our analysis, we were also able to exclude dysregulation in sensory feedback circuits and descending neuromodulatory control. These abnormalities on objective tests may aid in the development of novel approaches for disease monitoring.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Anne M E</ForeName><Initials>AME</Initials><Identifier Source="ORCID">0000-0001-6916-1329</Identifier><AffiliationInfo><Affiliation>Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maffitt</LastName><ForeName>Natalie J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Vecchio</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander University Erlangen-N&#xfc;rnberg, 91052 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKeating</LastName><ForeName>Katherine M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Mark R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Stuart N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soteropoulos</LastName><ForeName>Demetris S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/W004798/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain Commun</MedlineTA><NlmUniqueID>101755125</NlmUniqueID><ISSNLinking>2632-1297</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID</Keyword><Keyword MajorTopicYN="N">dysautonomia</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">myopathy</Keyword><Keyword MajorTopicYN="N">transcranial magnetic brain stimulation</Keyword></KeywordList><CoiStatement>The authors report no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>4</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37304792</ArticleId><ArticleId IdType="pmc">PMC10257363</ArticleId><ArticleId IdType="doi">10.1093/braincomms/fcad122</ArticleId><ArticleId IdType="pii">fcad122</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blomberg B, Mohn KG, Brokstad KA, et al. . Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27(9):1607&#x2013;1613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>McCrone P, Darbishire L, Ridsdale L, Seed P. The economic cost of chronic fatigue and chronic fatigue syndrome in UK primary care. Psychol Med. 2003;33(2):253&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">12622304</ArticleId></ArticleIdList></Reference><Reference><Citation>Collin SM, Crawley E, May MT, Sterne JA, Hollingworth W, UK CFS/ME National Outcomes Database . The impact of CFS/ME on employment and productivity in the UK: A cross-sectional study based on the CFS/ME national outcomes database. BMC Health Serv Res. 2011;11:217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3184626</ArticleId><ArticleId IdType="pubmed">21923897</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullinan J, Ni Chomhrai O, Kindlon T, Black L, Casey B. Understanding the economic impact of myalgic encephalomyelitis/chronic fatigue syndrome in Ireland: A qualitative study. HRB Open Res. 2020;3:88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7898356</ArticleId><ArticleId IdType="pubmed">33659857</ArticleId></ArticleIdList></Reference><Reference><Citation>
Office for National Statistics . Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. 2022.https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/6january2022 [Accessed 6.1.2022]</Citation></Reference><Reference><Citation>Dantzer R. Neuroimmune interactions: From the brain to the immune system and vice versa. Physiol Rev. 2018;98(1):477&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5866360</ArticleId><ArticleId IdType="pubmed">29351513</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluger BM, Krupp LB, Enoka RM. Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy. Neurology. 2013;80(4):409&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3589241</ArticleId><ArticleId IdType="pubmed">23339207</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald C, Newton J, Lai HM, Baker SN, Jones DE. Central nervous system dysfunction in primary biliary cirrhosis and its relationship to symptoms. J Hepatol. 2010;53(6):1095&#x2013;1100.</Citation><ArticleIdList><ArticleId IdType="pubmed">20810186</ArticleId></ArticleIdList></Reference><Reference><Citation>Blakemore SJ, Wolpert DM, Frith CD. Central cancellation of self-produced tickle sensation. Nat Neurosci. 1998;1(7):635&#x2013;640.</Citation><ArticleIdList><ArticleId IdType="pubmed">10196573</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuppuswamy A. The fatigue conundrum. Brain. 2017;140(8):2240&#x2013;2245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5806506</ArticleId><ArticleId IdType="pubmed">28899013</ArticleId></ArticleIdList></Reference><Reference><Citation>Milone M, Wong LJ. Diagnosis of mitochondrial myopathies. Mol Genet Metab. 2013;110(1&#x2013;2):35&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">23911206</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen DG, Lamb GD, Westerblad H. Skeletal muscle fatigue: Cellular mechanisms. Physiol Rev. 2008;88(1):287&#x2013;332.</Citation><ArticleIdList><ArticleId IdType="pubmed">18195089</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen AM, Patel SP, Smith JD, et al. . Chronic muscle weakness and mitochondrial dysfunction in the absence of sustained atrophy in a preclinical sepsis model. eLife. 2019;8:e49920.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6890461</ArticleId><ArticleId IdType="pubmed">31793435</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vries JM, Hagemans ML, Bussmann JB, van der Ploeg AT, van Doorn PA. Fatigue in neuromuscular disorders: Focus on Guillain-Barre syndrome and Pompe disease. Cell Mol Life Sci. 2010;67(5):701&#x2013;713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2824125</ArticleId><ArticleId IdType="pubmed">20196238</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson MD, Heckman CJ. Gain control mechanisms in spinal motoneurons. Front Neural Circuits. 2014;8:81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4114207</ArticleId><ArticleId IdType="pubmed">25120435</ArticleId></ArticleIdList></Reference><Reference><Citation>Rink C, Gortzen A, Veh RW, Pruss H. Serum antibodies targeting neurons of the monoaminergic systems in Guillain-Barre syndrome. J Neurol Sci. 2017;372:318&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pubmed">28017237</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies K, Ng WF. Autonomic nervous system dysfunction in primary Sjogren&#x2019;s syndrome. Front Immunol. 2021;12:702505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8350514</ArticleId><ArticleId IdType="pubmed">34381453</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarn J, Legg S, Mitchell S, Simon B, Ng WF. The effects of noninvasive vagus nerve stimulation on fatigue and immune responses in patients with primary Sjogren&#x2019;s syndrome. Neuromodulation. 2019;22(5):580&#x2013;585.</Citation><ArticleIdList><ArticleId IdType="pubmed">30328647</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: Initial validation of the fatigue impact scale. Clin Infect Dis. 1994;18(Suppl 1):S79&#x2013;S83.</Citation><ArticleIdList><ArticleId IdType="pubmed">8148458</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57:289&#x2013;300.</Citation></Reference><Reference><Citation>

Spider_plot. 2022.
https://uk.mathworks.com/matlabcentral/fileexchange/59561-spider_plot [Accessed 6.1.2022]</Citation></Reference><Reference><Citation>Hunter SK, McNeil CJ, Butler JE, Gandevia SC, Taylor JL. Short-interval cortical inhibition and intracortical facilitation during submaximal voluntary contractions changes with fatigue. Exp Brain Res. 2016;234(9):2541&#x2013;2551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5349854</ArticleId><ArticleId IdType="pubmed">27165508</ArticleId></ArticleIdList></Reference><Reference><Citation>Thickbroom GW, Sacco P, Kermode AG, et al. . Central motor drive and perception of effort during fatigue in multiple sclerosis. J Neurol. 2006;253(8):1048&#x2013;1053.</Citation><ArticleIdList><ArticleId IdType="pubmed">16607472</ArticleId></ArticleIdList></Reference><Reference><Citation>Kujirai T, Caramia MD, Rothwell JC, et al. . Corticocortical inhibition in human motor cortex. J Physiol. 1993;471:501&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1143973</ArticleId><ArticleId IdType="pubmed">8120818</ArticleId></ArticleIdList></Reference><Reference><Citation>De Doncker W, Dantzer R, Ormstad H, Kuppuswamy A. Mechanisms of poststroke fatigue. J Neurol Neurosurg Psychiatry. 2018;89(3):287&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">28939684</ArticleId></ArticleIdList></Reference><Reference><Citation>Agergaard J, Leth S, Pedersen TH, et al. . Myopathic changes in patients with long-term fatigue after COVID-19. Clin Neurophysiol. 2021;132(8):1974&#x2013;1981.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8102077</ArticleId><ArticleId IdType="pubmed">34020890</ArticleId></ArticleIdList></Reference><Reference><Citation>Alekseeva TM, Gavrilov YV, Kreis OA, Valko PO, Weber KP, Valko Y. Fatigue in patients with myasthenia gravis. J Neurol. 2018;265(10):2312&#x2013;2321.</Citation><ArticleIdList><ArticleId IdType="pubmed">30099585</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagani M, Lucini D. Chronic fatigue syndrome: A hypothesis focusing on the autonomic nervous system. Clin Sci (Lond). 1999;96(1):117&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">9857114</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitzke M, Stefanovic D, Meyer JJ, Schimpf S, Schonknecht P. Autonomic balance determines the severity of COVID-19 courses. Bioelectron Med. 2020;6(1):22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7683278</ArticleId><ArticleId IdType="pubmed">33292846</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Y, Yu Z, Yuan Y, et al. . Alteration of autonomic nervous system is associated with severity and outcomes in patients with COVID-19. Front Physiol. 2021;12:630038.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8170133</ArticleId><ArticleId IdType="pubmed">34093217</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtoglu E, Afsin A, Aktas I, Akturk E, Kutlusoy E, Cagasar O. Altered cardiac autonomic function after recovery from COVID-19. Ann Noninvasive Electrocardiol. 2022;27(1):e12916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8739610</ArticleId><ArticleId IdType="pubmed">34817120</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol MBA, Strous MTA, van Osch FHM, et al. . Heart-rate-variability (HRV), predicts outcomes in COVID-19. PLoS One. 2021;16(10):e0258841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8553073</ArticleId><ArticleId IdType="pubmed">34710127</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Moloney D, Finucane C, et al. . Fatigue following COVID-19 infection is not associated with autonomic dysfunction. PLoS One. 2021;16(2):e0247280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7906457</ArticleId><ArticleId IdType="pubmed">33630906</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacruz F, Artieda J, Pastor MA, Obeso JA. The anatomical basis of somaesthetic temporal discrimination in humans. J Neurol Neurosurg Psychiatry. 1991;54(12):1077&#x2013;1081.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1014683</ArticleId><ArticleId IdType="pubmed">1783921</ArticleId></ArticleIdList></Reference><Reference><Citation>Logan GD, Cowan WB, Davis KA. On the ability to inhibit simple and choice reaction time responses: A model and a method. J Exp Psychol Hum Percept Perform. 1984;10(2):276&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pubmed">6232345</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapia JA, Tohyama T, Poll A, Baker SN. The existence of the StartReact effect implies reticulospinal, not corticospinal, inputs dominate drive to motoneurons during voluntary movement. J Neurosci. 2022;42(40):7634-7647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9546468</ArticleId><ArticleId IdType="pubmed">36658461</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P, Gorelik Y, Zayyad H, et al. Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: A cross-sectional study of patients tested between March 2020 and November 2021. medRxiv. 2022:2022.01.05.22268800.</Citation></Reference><Reference><Citation>Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375(6585):1122&#x2013;1127.</Citation><ArticleIdList><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, et al. . Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23(2):210-216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies K, Dures E, Ng WF. Fatigue in inflammatory rheumatic diseases: Current knowledge and areas for future research. Nat Rev Rheumatol. 2021;17(11):651&#x2013;664.</Citation><ArticleIdList><ArticleId IdType="pubmed">34599320</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard Tripp N, Tarn J, Natasari A, et al. . Fatigue in primary Sjogren&#x2019;s syndrome is associated with lower levels of proinflammatory cytokines. RMD Open. 2016;2(2):e000282.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4964201</ArticleId><ArticleId IdType="pubmed">27493792</ArticleId></ArticleIdList></Reference><Reference><Citation>Druce KL, Bhattacharya Y, Jones GT, Macfarlane GJ, Basu N. Most patients who reach disease remission following anti-TNF therapy continue to report fatigue: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Rheumatology (Oxford). 2016;55(10):1786&#x2013;1790.</Citation><ArticleIdList><ArticleId IdType="pubmed">27330158</ArticleId></ArticleIdList></Reference><Reference><Citation>Stellwagen D, Beattie EC, Seo JY, Malenka RC. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci. 2005;25(12):3219&#x2013;3228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6725093</ArticleId><ArticleId IdType="pubmed">15788779</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewitus GM, Pribiag H, Duseja R, St-Hilaire M, Stellwagen D. An adaptive role of TNFalpha in the regulation of striatal synapses. J Neurosci. 2014;34(18):6146&#x2013;6155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6608116</ArticleId><ArticleId IdType="pubmed">24790185</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziemann U. TMS and drugs. Clin Neurophysiol. 2004;115(8):1717&#x2013;1729.</Citation><ArticleIdList><ArticleId IdType="pubmed">15261850</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipe A, Chernorudskiy A, Arbogast S, et al. . Defective endoplasmic reticulum-mitochondria contacts and bioenergetics in SEPN1-related myopathy. Cell Death Differ. 2021;28(1):123&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7853070</ArticleId><ArticleId IdType="pubmed">32661288</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorman GS, Elson JL, Newman J, et al. . Perceived fatigue is highly prevalent and debilitating in patients with mitochondrial disease. Neuromuscul Disord. 2015;25(7):563&#x2013;566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4502433</ArticleId><ArticleId IdType="pubmed">26031904</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Niermann KJ, Olsen N. Evidence for metabolic abnormalities in the muscles of patients with fibromyalgia. Curr Rheumatol Rep. 2000;2(2):131&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pubmed">11123050</ArticleId></ArticleIdList></Reference><Reference><Citation>Heckman CJ, Lee RH, Brownstone RM. Hyperexcitable dendrites in motoneurons and their neuromodulatory control during motor behavior. Trends Neurosci. 2003;26(12):688&#x2013;695.</Citation><ArticleIdList><ArticleId IdType="pubmed">14624854</ArticleId></ArticleIdList></Reference><Reference><Citation>Katafuchi T, Kondo T, Take S, Yoshimura M. Brain cytokines and the 5-HT system during poly I:C-induced fatigue. Ann N Y Acad Sci. 2006;1088:230&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pubmed">17192569</ArticleId></ArticleIdList></Reference><Reference><Citation>Cushing S, Bui T, Rose PK. Effect of nonlinear summation of synaptic currents on the input-output properties of spinal motoneurons. J Neurophysiol. 2005;94(5):3465&#x2013;3478.</Citation><ArticleIdList><ArticleId IdType="pubmed">16079193</ArticleId></ArticleIdList></Reference><Reference><Citation>Escorihuela RM, Capdevila L, Castro JR, et al. . Reduced heart rate variability predicts fatigue severity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis. J Transl Med. 2020;18(1):4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6943898</ArticleId><ArticleId IdType="pubmed">31906988</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton JL, Okonkwo O, Sutcliffe K, Seth A, Shin J, Jones DE. Symptoms of autonomic dysfunction in chronic fatigue syndrome. QJM. 2007;100(8):519&#x2013;526.</Citation><ArticleIdList><ArticleId IdType="pubmed">17617647</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>